revyve key facts
- Operator of a purpose-driven food-tech company intended to create replacement proteins from microorganisms.
- It has raised $52.5M; the latest was Later Stage VC ($28.1M) in Sep 2025.
- Notable investors include StartLife, Brabantse Ontwikkelings Maatschappij, Invest-NL (Investment Company), Oost NL, Thematic Technology Transfer — 14 tracked in total.
- revyve has filed 1 Form D with the SEC, most recently Nov 2014 ($40K sold to 26 investors).
- Status: Privately Held (backing).
Who backs revyve
14+- ·The complete investor list: 14 names
- ·Watch revyve: the Monday email on marks, rounds and moves
revyve funding rounds
No funding rounds for revyve are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How much has revyve raised?
revyve has filed 1 Form D with the SEC, most recently in Nov 2014 ($40,000 sold to 26 investors).
revyve investors
14 investors are on record for revyve, including StartLife, Brabantse Ontwikkelings Maatschappij, Invest-NL (Investment Company) and Oost NL.
About revyve
Operator of a purpose-driven food-tech company intended to create replacement proteins from microorganisms. The company specializes in ingredients for the production of animal-free food that can be used as egg replacers prepared using natural microorganisms, enabling customers to enjoy great-tasting foods without compromising on taste, texture, health, or sustainability.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Wageningen, Netherlands
- Founded
- 2019
- Employees
- 38
- Website
- revyve.bio/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
revyve doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.